Date: Jun 01, 2000 Source: pharmamedtechbi.com (
click here to go to the source)
Molecular Devices (bioanalytical measurement systems) has acquired LJL BioSystems (assay automation systems) in a $240mm stock swap. For each LJL BioSystems share, the shareholder will receive $16.19 in Molecular Devices stock, a (pr)43% premium based on the market average.